EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Kraig Biocraft Laboratories EBITDA Margin % Related Terms
Kraig Biocraft Laboratories EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KBLB vs AMTX, FF, RLEA: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Kraig Biocraft Laboratories's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kraig Biocraft Laboratories EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Kraig Biocraft Laboratories's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Kraig Biocraft Laboratories's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kraig Biocraft Laboratories (KBLB) has a EBITDA Margin % of 0.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Kraig Biocraft Laboratories and its competitors. According to the industry distribution chart, Kraig Biocraft Laboratories ranks #999999 out of 1584 companies in the Chemicals industry.
Is Kraig Biocraft Laboratories' EBITDA Margin % too high?
Kraig Biocraft Laboratories' current EBITDA Margin % is 0.00%. Based on the distribution chart, Kraig Biocraft Laboratories ranks #999999 out of 1584 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Kraig Biocraft Laboratories has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Kraig Biocraft Laboratories' EBITDA Margin % compare to AMTX and FF?
According to the Chemicals industry distribution chart, Kraig Biocraft Laboratories ranks #999999 out of 1584 companies for EBITDA Margin %. This places Kraig Biocraft Laboratories in the lower half of its industry. The industry median EBITDA Margin % is 9.64. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,584 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Kraig Biocraft Laboratories and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kraig Biocraft Laboratories's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kraig Biocraft Laboratories stock overvalued right now?
Kraig Biocraft Laboratories (KBLB) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Kraig Biocraft Laboratories' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Kraig Biocraft Laboratories (KBLB), the current EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fiber using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; Dragon Silk, which combines the elasticity of Monster Silk with additional high-strength elements of native spider silk; Spydasilk; and Spydra.
30GF Score
Get the complete analysis for KBLB
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KBLB has been successfully added to your 
